Literature DB >> 29503074

Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation.

Céline Lecointre1, Valérie Simon1, Clément Kerneur1, Frédéric Allemand2, Aurélie Fournet2, Ingrid Montarras1, Jean-Luc Pons2, Muriel Gelin2, Constance Brignatz1, Serge Urbach3, Gilles Labesse4, Serge Roche5.   

Abstract

The pseudo-kinase and signaling protein Pragmin has been linked to cancer by regulating protein tyrosine phosphorylation via unknown mechanisms. Here we present the crystal structure of the Pragmin 906-1,368 amino acid C terminus, which encompasses its kinase domain. We show that Pragmin contains a classical protein-kinase fold devoid of catalytic activity, despite a conserved catalytic lysine (K997). By proteomics, we discovered that this pseudo-kinase uses the tyrosine kinase CSK to induce protein tyrosine phosphorylation in human cells. Interestingly, the protein-kinase domain is flanked by N- and C-terminal extensions forming an original dimerization domain that regulates Pragmin self-association and stimulates CSK activity. A1329E mutation in the C-terminal extension destabilizes Pragmin dimerization and reduces CSK activation. These results reveal a dimerization mechanism by which a pseudo-kinase can induce protein tyrosine phosphorylation. Further sequence-structure analysis identified an additional member (C19orf35) of the superfamily of dimeric Pragmin/SgK269/PEAK1 pseudo-kinases.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CSK; cancer; cell adhesion; protein tyrosine phosphorylation; pseudo-kinase; signaling

Mesh:

Substances:

Year:  2018        PMID: 29503074     DOI: 10.1016/j.str.2018.01.017

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  16 in total

Review 1.  PseudoGTPase domains in p190RhoGAP proteins: a mini-review.

Authors:  Amy L Stiegler; Titus J Boggon
Journal:  Biochem Soc Trans       Date:  2018-12-04       Impact factor: 5.407

2.  Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.

Authors:  Matthew A Held; Emily Greenfest-Allen; Su Su; Christian J Stoeckert; Matthew P Stokes; Don M Wojchowski
Journal:  Cell Signal       Date:  2020-02-03       Impact factor: 4.315

3.  The N-Terminal GTPase Domain of p190RhoGAP Proteins Is a PseudoGTPase.

Authors:  Amy L Stiegler; Titus J Boggon
Journal:  Structure       Date:  2018-08-30       Impact factor: 5.006

4.  PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization.

Authors:  Mitchell L Lopez; Megan Lo; Jennifer E Kung; Małgorzata Dudkiewicz; Gwendolyn M Jang; John Von Dollen; Jeffrey R Johnson; Nevan J Krogan; Krzysztof Pawłowski; Natalia Jura
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-16       Impact factor: 11.205

5.  Tracing the origin and evolution of pseudokinases across the tree of life.

Authors:  Annie Kwon; Steven Scott; Rahil Taujale; Wayland Yeung; Krys J Kochut; Patrick A Eyers; Natarajan Kannan
Journal:  Sci Signal       Date:  2019-04-23       Impact factor: 8.192

6.  Piquing our interest: Insights into the role of PEAK3 in signaling and disease.

Authors:  Michael D Paul; Hayarpi Torosyan; Natalia Jura
Journal:  Sci Signal       Date:  2022-02-22       Impact factor: 9.517

7.  Proteo3Dnet: a web server for the integration of structural information with interactomics data.

Authors:  Guillaume Postic; Jessica Andreani; Julien Marcoux; Victor Reys; Raphaël Guerois; Julien Rey; Emmanuelle Mouton-Barbosa; Yves Vandenbrouck; Sarah Cianferani; Odile Burlet-Schiltz; Gilles Labesse; Pierre Tufféry
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

Review 8.  Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis.

Authors:  Audrey Sirvent; Rudy Mevizou; Dana Naim; Marie Lafitte; Serge Roche
Journal:  Cancers (Basel)       Date:  2020-07-23       Impact factor: 6.639

9.  AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network.

Authors:  Afnan Abu-Thuraia; Marie-Anne Goyette; Jonathan Boulais; Carine Delliaux; Chloé Apcher; Céline Schott; Rony Chidiac; Halil Bagci; Marie-Pier Thibault; Dominique Davidson; Mathieu Ferron; André Veillette; Roger J Daly; Anne-Claude Gingras; Jean-Philippe Gratton; Jean-François Côté
Journal:  Nat Commun       Date:  2020-07-17       Impact factor: 14.919

10.  Conformational Insight on WT- and Mutated-EGFR Receptor Activation and Inhibition by Epigallocatechin-3-Gallate: Over a Rational Basis for the Design of Selective Non-Small-Cell Lung Anticancer Agents.

Authors:  Cristina Minnelli; Emiliano Laudadio; Giovanna Mobbili; Roberta Galeazzi
Journal:  Int J Mol Sci       Date:  2020-03-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.